2018 American Transplant Congress
De Novo Use of Extended Released Tacrolimus (Meltdose, EnvasusR)) after OLT – Does the Colonic Resorption Influences the Outcome?
Department of Transplantation, Medical University of Vienna, Vienna, Austria.
Introduction: Immunosuppression after OLT has reached a quite high standard with an excellent evidence base. However, there is still a lack of data for the…2018 American Transplant Congress
Nontuberculous Mycobacteria in Lung Transplant Recipients: Prevalence, Risk Factors and Impact on Survival and Graft Function
University of Alberta, Edmonton, Canada.
BACKGROUND. Nontuberculous mycobacteria (NTM) may colonize or infect lung transplant patients. Due to differences in populations studied and geographical diversity of NTM, risk factors for…2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…2018 American Transplant Congress
Pregnancy Outcomes after Living Liver Donation
Introduction: Women who have previously donated a kidney are at increased risk of pre-eclampsia. Nearly half of living liver donors are women of child-bearing age.…2018 American Transplant Congress
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients
Recent guidelines support metformin as a therapeutic option in diabetic patients with mild to moderate renal insufficiency. The frequency and outcomes of metformin use in…2018 American Transplant Congress
Mortality and ESRD in Older Live Kidney Donors with Hypertension
1Johns Hopkins, Baltimore; 2University of Colorado, Aurora; 3SRTR, Minneapolis.
Hypertension in otherwise healthy screened older kidney donor candidates is viewed as relatively benign, yet the long-term outcome of older donors with hypertension is unclear.…2018 American Transplant Congress
Prospective Multicenter Validation of Human Transitional B Cell Cytokines as a Predictive Biomarker in Renal Transplantation
1UPMC, Pittsburgh; 2UCL, London, United Kingdom.
In renal transplantation, non-invasive biomarkers are needed to identify patients at risk for poor outcomes and guide pre-emptive therapy. Here, we assessed B cell cytokines…2018 American Transplant Congress
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection
BackgroundThe human T-lymphotropic virus (HTLV-I), which is endemic in southern Japan, is recognized as the cause of adult T cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy…2018 American Transplant Congress
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes
INTRODUCTIONGraft steatosis is a risk factor for early allograft dysfunction (EAD) and is thought to portend inferior transplant outcomes. The impact of total steatosis, combining…2018 American Transplant Congress
Addressing the “Crisis” in Pancreas Transplant Volume Using a Multidisciplinary Approach
Surgery, University of Maryland, Baltimore, MD.
Background: Due in part to the recently revised pancreas allocation system, patients who are listed for simultaneous pancreas and kidney (SPK) transplantation can be transplanted…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 155
- Next Page »